Long-Term Safety of Canakinumab in Patients with Gouty Arthritis.

被引：0
|
作者：
So, Alexander [1 ]
Alten, Reike [2 ]
Schumacher, H. Ralph [3 ,4 ]
Bloch, Mark [5 ]
Bardin, Thomas [6 ]
John, Markus R. [7 ]
Krammer, Gerhard [7 ]
Nebesky, Jan Michael [7 ]
Tao, Aiyang [8 ]
Schlesinger, Naomi [9 ]
机构：
[1] Univ Lausanne, CHUV, Lausanne, Switzerland
[2] Charite, D-13353 Berlin, Germany
[3] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[4] VA Med Ctr, Philadelphia, PA USA
[5] Holdsworth House Med Practice, Sydney, NSW, Australia
[6] Hop Lariboisiere, F-75475 Paris, France
[7] Novartis Pharma AG, Basel, Switzerland
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] UMDNJ RWJMS, New Brunswick, NJ USA
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
144
引用
收藏
页码：S63 / S63
页数：1
相关论文
共 50 条
  • [21] Golimumab Retention Rate in Patients with Rheumatoid Arthritis. Predictors of Long-Term Retention
    Serrano, Belen
    Gonzalez, Carlos M.
    Gonzalez, Roberto
    Martinez-Barrio, Julia
    Gabriel Ovalles-Bonilla, Juan
    Carlos Nieto, Juan
    Janta, Iustina
    Valor, Larissa
    Lopez Longo, Francisco Javier
    Monteagudo, Indalecio
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [22] Long-term use of Enbrel® in patients with DMARD-refractory rheumatoid arthritis.
    Moreland, LM
    Cohen, SB
    Baumgartner, SW
    Schiff, MH
    Tindall, EA
    Bulpitt, K
    Burge, DJ
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S270 - S270
  • [23] Long-term use of etanercept in patients with DMARD-refractory rheumatoid arthritis.
    Moreland, LM
    Cohen, SB
    Baumgartner, S
    Schiff, M
    Tindall, EA
    Burge, DJ
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S401 - S401
  • [24] Unusual presentation of gouty arthritis.
    Venkatesan, J.
    Rosell, W.
    Shetty, S.
    Morano, P.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (01) : S248 - S248
  • [25] Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience
    Yocum, DE
    Furst, DE
    Bensen, WG
    Burch, FX
    Borton, MA
    Mengle-Gaw, LJ
    Schwartz, BD
    Wisememandle, W
    Mekki, QA
    RHEUMATOLOGY, 2004, 43 (08) : 992 - 999
  • [26] Safety of adalimumab in long-term treatment of patients with rheumatoid arthritis
    Schiff, M
    Burmester, GR
    Kent, J
    Pangan, A
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P203 - P203
  • [27] Long-term efficacy and safety of secukinumab in patients with psoriatic arthritis
    Mahmood, Aysal
    Ali, Abraish
    Haider, Hoorain
    Zulfiqar, Beenish
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 118 : 152 - 154
  • [28] Efficacy and Safety of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis: Results from an Open-Label Long-Term Followup Study
    Brunner, Hermine L.
    Ruperto, Nicolino
    Quartier, Pierre
    Constantin, Tamas
    Alexeeva, Ekaterina
    Schneider, Rayfel
    Kone-Paut, Isabelle
    Schikler, Kenneth
    Marzan, Katherine
    Wulffraat, Nico
    Padeh, Shai
    Chasnyk, Vyacheslav
    Wouters, Carine
    Kuemmerle-Deschner, Jasmin B.
    Kallinich, Tilmann
    Lauwerys, Bernard
    Haddad, Elie
    Nasonov, Evgeny L.
    Trachana, Maria
    Vougiouka, Olga
    Leon, Karolynn
    Speziale, Antonio
    Lheritier, Karine
    Vritzali, Eleni
    Lovell, Daniel J.
    Martini, Alberto
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [29] Long-Term Safety and Effectiveness of Canakinumab in Patients with MKD/HIDS: Interim Analysis of the RELIANCE Registry
    Oommen, Prasad T.
    Kallinich, Tilmann
    Rech, Juergen
    Blank, Norbert
    Weber-Arden, Julia
    Kuemmerle-Deschner, Jasmin B.
    RHEUMATOLOGY AND THERAPY, 2025, 12 (01) : 137 - 155
  • [30] Long-term safety and efficacy experience with etanercept (Enbrel®) in children with polyarticular juvenile rheumatoid arthritis.
    Lovell, D
    Reiff, A
    Jones, OY
    Schneider, R
    Giannini, EH
    Whitmore, JB
    White, B
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S436 - S436
12345